# ASIP

## Overview
The agouti signaling protein (ASIP) gene encodes a glycoprotein that plays a pivotal role in the regulation of pigmentation and metabolic processes. The protein, categorized as an endogenous antagonist of G-protein-coupled receptors (GPCRs), particularly targets melanocortin receptors such as MC1R and MC4R. Through its interaction with MC1R, ASIP influences the balance between eumelanin and pheomelanin production, thereby affecting skin, hair, and eye color. Structurally, ASIP features a cysteine-rich C-terminal domain with an inhibitor cystine knot (ICK) fold, which is crucial for its binding affinity and functional modulation of melanocortin receptors (Yu2007Chemical). Beyond pigmentation, ASIP's interaction with MC4R in the brain is implicated in metabolic regulation, including obesity-related pathways (McNulty2005Structures). Genetic variations in the ASIP gene have been associated with diverse clinical outcomes, including increased melanoma risk and pigmentary phenotypes, underscoring its significance in human health and disease (Taylor2014Inherited; Nan2009Genetic).

## Structure
The agouti signaling protein (ASIP) is a glycoprotein with a sequence of 110 amino acids following the removal of its signal peptide. It features a cysteine-rich C-terminal domain essential for its high-affinity binding to melanocortin receptors, specifically MC1R and MC4R. This domain contains 10 cysteines that form five disulfide bonds, arranged in an inhibitor cystine knot (ICK) fold, a structural motif also found in invertebrate toxins (Yu2007Chemical). The ICK fold is characterized by specific disulfide linkages, including bonds between Cys93-Cys108, Cys116-Cys123, and Cys111-Cys132 (Yu2007Chemical).

ASIP undergoes post-translational modifications, such as glycosylation, which may influence its function and stability (Yu2007Chemical). The protein functions as a monomer, indicating it lacks a quaternary structure (Yu2007Chemical). The human ASIP gene is expressed in various tissues, including adipose tissue, heart, testis, and skin, and may be involved in lipid metabolism and hair color regulation (Virador2000Bioactive). The protein's structure and function are closely related to its role as an endogenous GPCR antagonist, impacting pigmentation and metabolic processes (Yu2007Chemical).

## Function
The ASIP (agouti signaling protein) gene encodes a protein that plays a crucial role in the regulation of pigmentation in humans. ASIP functions as an antagonist to the melanocortin 1 receptor (MC1R), a receptor involved in the production of melanin, the pigment responsible for skin, hair, and eye color. By inhibiting MC1R, ASIP promotes the production of pheomelanin, which results in lighter pigmentation, as opposed to eumelanin, which leads to darker pigmentation (Ollmann1998Interaction; Kanetsky2002A).

In melanocytes, the cells responsible for melanin production, ASIP affects the signaling pathways that regulate the expression and activity of melanogenic enzymes such as tyrosinase and Tyrp1. These enzymes are critical for melanin synthesis, and ASIP has been shown to decrease their mRNA levels and catalytic function, thereby influencing pigmentation outcomes (Virador2000Bioactive).

ASIP is active in the skin and hair follicles, where it modulates the balance between different types of melanin, contributing to variations in pigmentation phenotypes among individuals. This modulation is part of a broader system involving other genes and receptors that collectively determine pigmentation traits (Wilson1995Structure; Sturm2009Molecular).

## Clinical Significance
Mutations and alterations in the expression of the ASIP gene are associated with several clinical conditions. In mice, mutations in ASIP can lead to a pleiotropic syndrome characterized by a yellow coat color, obesity, hyperglycemia, hyperinsulinemia, increased susceptibility to hyperplasia and carcinogenesis, and lethality in homozygous yellow mice. These mutations result in the wild-type protein being produced at abnormally high levels, which can also promote hepatocellular carcinogenesis (Reissmann2013Pleiotropic).

In humans, genetic variations at the ASIP locus have been linked to an increased risk of melanoma. The TG/TG diplotype of ASIP is associated with a significantly increased hazard of melanoma-specific death compared to the GG/GG diplotype (Taylor2014Inherited). The ASIP AH haplotype, which includes the rs4911414 variant allele [T] and rs1015362 major allele [G], is associated with increased melanoma risk and skin sensitivity to sun (Helsing2012MC1R; Nan2009Genetic). Variants at the ASIP locus have also been associated with pigmentary phenotypes such as fair skin color, which is a known risk factor for skin cancer (Nan2009Genetic). These genetic variations highlight the role of ASIP in pigmentation and its potential impact on skin cancer susceptibility.

## Interactions
The agouti signaling protein (ASIP) is known for its interactions with melanocortin receptors, particularly MC1R and MC4R. ASIP acts as an inverse agonist at these receptors, inhibiting their activity. This interaction is crucial for its role in pigmentation, as it promotes the production of red/yellow pheomelanin and inhibits black/brown eumelanin through its action on MC1R (McNulty2005Structures; Yu2007Chemical). 

ASIP's structure includes a cysteine-rich C-terminal domain that forms a network of disulfide bonds, which is essential for its binding affinity to these receptors. The protein exhibits an inhibitor cystine knot (ICK) fold motif, a structural feature that allows it to modulate G-protein-coupled receptors (GPCRs) (McNulty2005Structures; Yu2007Chemical). 

In addition to its role in pigmentation, ASIP interacts with MC4R in the brain, where it mimics the signaling of agouti-related protein (AgRP), influencing obesity and metabolic processes (McNulty2005Structures). The interactions of ASIP with these receptors involve specific contacts, such as the RFF triplet in the central loop, which likely interacts with a negatively charged transmembrane site in the receptor (McNulty2005Structures).


## References


[1. (McNulty2005Structures) Joseph C. McNulty, Pilgrim J. Jackson, Darren A. Thompson, Biaoxin Chai, Ira Gantz, Gregory S. Barsh, Philip E. Dawson, and Glenn L. Millhauser. Structures of the agouti signaling protein. Journal of Molecular Biology, 346(4):1059–1070, March 2005. URL: http://dx.doi.org/10.1016/j.jmb.2004.12.030, doi:10.1016/j.jmb.2004.12.030. This article has 69 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2004.12.030)

[2. (Ollmann1998Interaction) M. M. Ollmann, M. L. Lamoreux, B. D. Wilson, and G. S. Barsh. Interaction of agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes &amp; Development, 12(3):316–330, February 1998. URL: http://dx.doi.org/10.1101/gad.12.3.316, doi:10.1101/gad.12.3.316. This article has 167 citations.](https://doi.org/10.1101/gad.12.3.316)

[3. (Nan2009Genetic) Hongmei Nan, Peter Kraft, David J. Hunter, and Jiali Han. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in caucasians. International Journal of Cancer, 125(4):909–917, June 2009. URL: http://dx.doi.org/10.1002/ijc.24327, doi:10.1002/ijc.24327. This article has 163 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.24327)

[4. (Helsing2012MC1R) Per Helsing, Dag A Nymoen, Helge Rootwelt, Mari Vårdal, Lars A. Akslen, Anders Molven, and Per A. Andresen. Mc1r, asip, tyr, and tyrp1 gene variants in a population‐based series of multiple primary melanomas. Genes, Chromosomes and Cancer, 51(7):654–661, March 2012. URL: http://dx.doi.org/10.1002/gcc.21952, doi:10.1002/gcc.21952. This article has 20 citations.](https://doi.org/10.1002/gcc.21952)

[5. (Reissmann2013Pleiotropic) Monika Reissmann and Arne Ludwig. Pleiotropic effects of coat colour-associated mutations in humans, mice and other mammals. Seminars in Cell &amp; Developmental Biology, 24(6–7):576–586, June 2013. URL: http://dx.doi.org/10.1016/j.semcdb.2013.03.014, doi:10.1016/j.semcdb.2013.03.014. This article has 118 citations.](https://doi.org/10.1016/j.semcdb.2013.03.014)

[6. (Sturm2009Molecular) R. A. Sturm. Molecular genetics of human pigmentation diversity. Human Molecular Genetics, 18(R1):R9–R17, April 2009. URL: http://dx.doi.org/10.1093/hmg/ddp003, doi:10.1093/hmg/ddp003. This article has 274 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp003)

[7. (Yu2007Chemical) Bin Yu and Glenn L. Millhauser. Chemical disulfide mapping identifies an inhibitor cystine knot in the agouti signaling protein. FEBS Letters, 581(29):5561–5565, November 2007. URL: http://dx.doi.org/10.1016/j.febslet.2007.10.062, doi:10.1016/j.febslet.2007.10.062. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.febslet.2007.10.062)

[8. (Taylor2014Inherited) Nicholas J. Taylor, Anne S. Reiner, Colin B. Begg, Anne E. Cust, Klaus J. Busam, Hoda Anton‐Culver, Terence Dwyer, Lynn From, Richard P. Gallagher, Stephen B. Gruber, Stefano Rosso, Kirsten A. White, Roberto Zanetti, Irene Orlow, Nancy E. Thomas, Timothy R. Rebbeck, Marianne Berwick, and Peter A. Kanetsky. Inherited variation at mc1r and asip and association with melanoma‐specific survival. International Journal of Cancer, 136(11):2659–2667, November 2014. URL: http://dx.doi.org/10.1002/ijc.29317, doi:10.1002/ijc.29317. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.29317)

[9. (Kanetsky2002A) Peter A. Kanetsky, Jennifer Swoyer, Saarene Panossian, Robin Holmes, DuPont Guerry, and Timothy R. Rebbeck. A polymorphism in the agouti signaling protein gene is associated with human pigmentation. The American Journal of Human Genetics, 70(3):770–775, March 2002. URL: http://dx.doi.org/10.1086/339076, doi:10.1086/339076. This article has 151 citations.](https://doi.org/10.1086/339076)

[10. (Wilson1995Structure) Brent D. Wilson, Michael M. Ollmann, Lana Kang, Markus Stoffel, Graeme I. Bell, and Gregory S. Barsh. Structure and function of asp, the human homolog of the mouse agouti gene. Human Molecular Genetics, 4(2):223–230, 1995. URL: http://dx.doi.org/10.1093/hmg/4.2.223, doi:10.1093/hmg/4.2.223. This article has 247 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/4.2.223)

[11. (Virador2000Bioactive) Victoria M. Virador, Chie Santis, Minao Furumura, Hubert Kalbacher, and Vincent J. Hearing. Bioactive motifs of agouti signal protein. Experimental Cell Research, 259(1):54–63, August 2000. URL: http://dx.doi.org/10.1006/EXCR.2000.4975, doi:10.1006/excr.2000.4975. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/EXCR.2000.4975)